GELITA and Black Drop collaborate on GelMA bioinks for 3D bioprinting research

• GELITA, a German manufacturer of collagen proteins and gelatin used in food, pharmaceutical, and biomedical applications, has signed a research and development agreement with Black Drop, a biotechnology company advancing 3D bioprinting technologies for biomedical research and pharmaceutical applications. The collaboration will focus on developing bioinks for biomedical uses, including three-dimensional tissue models and implants. […]

GELITA, a German manufacturer of collagen proteins and gelatin used in food, pharmaceutical, and biomedical applications, has signed a research and development agreement with Black Drop, a biotechnology company advancing 3D bioprinting technologies for biomedical research and pharmaceutical applications. The collaboration will focus on developing bioinks for biomedical uses, including three-dimensional tissue models and implants. Work combines the material science expertise of the collagen protein producer with Black Drop’s experience in customized 3D bioprinting systems. Research under the agreement will explore opportunities for novel methacrylated gelatin (GelMA) formulation on the company’s MEDELLAPRO Ultra Low Endotoxin Gelatin. Both organizations plan to conduct practical applicatio